Common Rheumatoid Arthritis Drug Won't Raise Blood Cancer Risk

Related Encyclopedia • Alzheimer's Disease • Arthritis • Arthroscopy & Arthroscopic Surgery • Autoimmune Diseases and Disorders More... Related Healthscout Videos The On-X Valve PROACT Trial The On-X Heart Valve: Longevity With Less Reliance on Coumadin Tissue Valves vs. Mechanical Valves What is the difference between heart valve repair and replacement? More... Related Animations • Alzheimer's Disease Video Animation • Erectile Dysfunction • Rheumatoid Arthritis • What is a Heart Attack? More... Related Drug Information • Actonel • Coumadin • Detrol LA • Ditropan XL More... Related News Articles • If Parents Had Alzheimer's, Aging May Come Early • A Pill to Prevent Hearing Loss? • Working With Robots May Help After a Stroke • Fast Arrival at Hospital After Stroke Pays Off More...

Page:  << Prev | 1 | 2 | 3

According to Wilson, cyclophosphamide is no one's first choice for treatment and is only used in the more severe cases. "You're sort of choosing between two evils," Wilson said. "No one wants to jump out of a perfectly good airplane, but if that airplane had two engines, and one was on fire, I might strap on that parachute and jump."

The study did not present data on any risks associated with new biologic medications, such as Embrel, Humira, and Remicade, which have been available since about 2000, Lindsey and Wilson said. There have been other studies with positive results for one category of these drugs, called TNF-alpha inhibitors, Wilson said. For severe cases, "when we treat them aggressively with a biologic modifier, perhaps we are bringing their risk down to similar to the general population," he said.

More information

Text Continues Below

---

There's more on rheumatoid arthritis at the Arthritis Foundation.

Page:  << Prev | 1 | 2 | 3